Abingdon Health PLC ABDX

Morningstar Rating
GBX8.50 0.00 (0.00%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ABDX is trading at a LOCK|TVc%v premium.
Price
£0.09
Fair Value
LOCK|L@X%@LB
Uncertainty
LOCK|mVj
1-Star Price
LOCK|?&Hyj^
5-Star Price
LOCK|zs!HX$
Economic Moat
LOCK|yc
Capital Allocation
—

Trading Information

Previous Close Price
GBX8.50
Day Range
GBX8.00–9.00
52-Week Range
GBX5.50–13.00
Bid/Ask
GBX0.00 / GBX0.00
Shares Outstanding
435.07M
Market Cap
GBX3.70B
Volume/Avg
32,459 / 99,736

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
3.20
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. The Company operates in the UK, USA/Canada, Europe, and rest of world.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
131

Valuation

Metric
ABDX
Price/Earnings (Normalized)
—
Price/Book Value
6.34
Price/Sales
3.20
Price/Cash Flow
—
Price/Earnings
ABDX

Financial Strength

Metric
ABDX
Quick Ratio
1.71
Current Ratio
1.91
Interest Coverage
−44.78
Quick Ratio
ABDX

Profitability

Metric
ABDX
Return on Assets (Normalized)
−14.91%
Return on Equity (Normalized)
−27.69%
Return on Invested Capital (Normalized)
−21.69%
Return on Assets
ABDX

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|J&tf&Q>>LOCK|M@$248B
Danaher Corp
DHR
LOCK|CH?dD?&$LOCK|fg$155B
IDEXX Laboratories Inc
IDXX
LOCK|CCNZGv>LOCK|$xJ$53B
Agilent Technologies Inc
A
LOCK|#@^!VkrLOCK|#V$48B
Waters Corp
WAT
LOCK|<%$y%BLOCK|H#$43B
IQVIA Holdings Inc
IQV
LOCK|%b#!M<LOCK|c$#&#$41B
Mettler-Toledo International Inc
MTD
LOCK|<gqc<VhLOCK|JCW<$$33B
Labcorp Holdings Inc
LH
LOCK|hL!Q@?l&LOCK|@!$F%$30B
Illumina Inc
ILMN
LOCK|%nl?$XLOCK|&M#rP$29B
Quest Diagnostics Inc
DGX
LOCK|q$%>>sLOCK|g>Pbp$28B

Sponsor Center